Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the easy-accordion-free domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u144920493/domains/currencyveda.com/public_html/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u144920493/domains/currencyveda.com/public_html/wp-includes/functions.php on line 6114
Entero Healthcare Solutions IPO Opens with Moderate Initial Interest - CurrencyVeda
TOP NEWS

Entero Healthcare Solutions IPO Opens with Moderate Initial Interest

Australian Premium

February 9, 2023

New Delhi, India

Entero Healthcare Solutions IPO Opens Today

Grey Market Premium Reflects Positive Sentiment

The much-anticipated initial public offering (IPO) of Entero Healthcare Solutions Limited has opened today, aiming to raise ₹1600 crore through the issuance of fresh shares. Here’s a breakdown of the key details and early market sentiment:

Grey Market Premium (GMP)

Market observers report a grey market premium (GMP) of ₹126 for Entero Healthcare Solutions shares, indicating an early demand for the company’s stock even before official listing.

Subscription Status

As of the initial bidding period, subscription stands at 0.01 times for the overall offering, with the retail portion subscribed 0.08 times and the employees’ portion at 0.05 times. While interest is evident, subscription figures suggest a moderate initial response from investors.

Price Band and Lot Size

Entero Healthcare Solutions has set a price band of ₹1195 to ₹1258 per equity share for its IPO. Investors can apply for shares in lots, with each lot comprising 11 company shares.

Allocation and Listing

The allocation of shares is expected to be finalized on 14th February 2024, with Link Intime India Private Limited serving as the official registrar. Entero Healthcare Solutions plans to list its shares on both the BSE and NSE, with the anticipated listing date set for 16th February 2024.

Investor Considerations

Investors evaluating Entero Healthcare Solutions IPO should carefully assess factors such as the company’s fundamentals, industry outlook, and valuation against their investment objectives. Monitoring subscription trends leading up to the closing date can provide valuable insights into investor sentiment.

As the IPO progresses, market dynamics may shift, influencing both subscription levels and grey market premiums. Prospective investors are advised to stay informed and conduct thorough due diligence before making investment decisions.

In summary, while Entero Healthcare Solutions IPO opens with moderate initial interest, the grey market premium suggests positive sentiment among investors. As the subscription period progresses, market reactions will continue to shape the trajectory of this highly anticipated offering.

Entero Healthcare Solutions IPO opens with a price band of ₹1195-₹1258 per share. Initial subscription is low, but grey market premium is positive.

Also Read: Indian Rupee Strengthens Against US Dollar Amid RBI Decision

Check Latest Q3 Earnings

Disclaimer:

CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.